CIA
NVRO

CSat Investment Advisory’s NEVRO CORP. NVRO Stock Holding History

CSat Investment Advisory’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-97
Closed -$14K – 996
2020
Q3 		$14K Buy
97
+14
+17% +$1.87K ﹤0.01% 976
2020
Q2 		$10K Buy
+83
New +$9.84K ﹤0.01% 1049

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CSat Investment Advisory's NVRO Position: Q4 2020 in Review

CSat Investment Advisory sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 97 shares — an estimated $14K sold.

CSat Investment Advisory first reported a position in NVRO in Q2 2020 and held it in 2 quarters. The position peaked at $14K in Q3 2020. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • CSat Investment Advisory reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 97 NEVRO CORP. shares in Q4 2020, an estimated $14K.
  • CSat Investment Advisory first reported a position in NEVRO CORP. in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's NEVRO CORP. position peaked at $14K in Q3 2020.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.